Decision-Making in Testing and Treatment of RET-Altered Lung and Thyroid Cancers
Selpercatinib in RET-altered Thyroid Cancers with Dr. Lori WirthПодробнее
Personalized treatment of RET-altered thyroid cancersПодробнее
Selpercatinib for RET-Altered Thyroid CancersПодробнее
Extent of surgical treatment for DTC: Shared decision making with your surgeon 246Подробнее
Surgical Decision-Making for an Aggressive Thyroid TumorПодробнее
The Role of the Patient & the Physician in Thyroid Cancer Care with Dr. HaymartПодробнее
Pralsetinib for Advanced or Metastatic RET-Altered Thyroid Cancer with Dr. Vivek SubbiahПодробнее
Management of anaplastic thyroid cancer with Dr Cabanillas 144Подробнее
A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET AlterationsПодробнее
The Future of RET-Specific TherapyПодробнее
TCGA: Papillary Thyroid Carcinoma Analysis - Thomas GiordanoПодробнее
RET Mutations in Lung and Thyroid CancersПодробнее
Improving Outcomes in Molecularly Altered NSCLC Through Precision Testing and TreatmentПодробнее
Progress in Treating Advanced Thyroid Cancers with Dr. Wirth | Targeted Therapy InsightsПодробнее
Personalized Treatment Approaches in Advanced Thyroid Cancer ManagementПодробнее
Frequency of RET Alterations in Thyroid CancersПодробнее
The Application of Molecular Testing to Improve Thyroid Nodule CareПодробнее
From Diagnosis to Treatment of Thyroid CancerПодробнее
Targeted therapies (i.e.: multi-kinase inhibitors, RET, NTRK inhibitors) in advanced disease. 251Подробнее